Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include non-mutated B cell antigens

Patients with chronic lymphocytic leukemia (CLL) who relapse after allogeneic transplant may achieve durable remission following donor lymphocytes infusion (DLI), demonstrating the potency of donor-derived immunity in eradicating tumor. We sought to elucidate the antigenic basis of the effective gra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marina, Ovidiu, Hainz, Ursula, Biernacki, Melinda A., Zhang, Wandi, Cai, Ann, Duke-Cohan, Jonathan S., Liu, Fenglong, Brusic, Vladimir, Neuberg, Donna, Kutok, Jeffery L., Alyea, Edwin P., Canning, Christine M., Soiffer, Robert J., Ritz, Jerome, Wu, Catherine J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852266/
https://ncbi.nlm.nih.gov/pubmed/20124481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-3143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados